Animal models of FVIIa gene expression: their role in the future development of haemophilia treatment.

Haemophilia : the Official Journal of the World Federation of Hemophilia
A ObergfellM Ezban

Abstract

The development of inhibitors to replacement factor therapy is a serious complication in the treatment of patients with haemophilia and requires use of bypassing agents to prevent uncontrolled bleeding. The efficacy of recombinant factor VIIa (rFVIIa) as a bypassing agent in patients with haemophilia has been demonstrated in case studies and clinical trials. However, the perception of a short plasma half-life and consequent need for repeated daily injections means that long-term prophylaxis could potentially be limiting. Canine haemophilia models using a gene transfer approach have been used to evaluate the continuous expression of FVIIa in dogs. These studies show improvement in measurable bleeding parameters that have important clinical ramifications for patients with haemophilia. The combination of gene transfer as the method of delivery and FVII as the transgene overcomes issues associated with the short plasma half-life of rFVIIa, and represents a potentially attractive novel approach to haemostasis in patients with haemophilia and other platelet disorders.

References

Sep 14, 2001·Haemophilia : the Official Journal of the World Federation of Hemophilia·H A CooperU Hedner
Dec 6, 2001·Seminars in Hematology·U Hedner
Apr 2, 2004·The Journal of Clinical Investigation·Paris MargaritisKatherine A High
Oct 14, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·J-M R Saint-RemyJ Oldenburg
May 7, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·G YoungD J Nugent
Nov 25, 2006·Haemophilia : the Official Journal of the World Federation of Hemophilia·E BerntorpC Hart
Apr 7, 2007·Current Opinion in Hematology·Ulla Hedner
Aug 21, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·D M DiMicheleE Santagostino
Jan 31, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·S HayaJ A Aznar
Apr 10, 2008·The Journal of Clinical Investigation·Majed N AljamaliKatherine A High
Jan 20, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·V Jiménez-YusteF Hernández-Navarro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.